Change in Bank Control Notices; Acquisition of Shares of Bank or Bank Holding Companies, 33094 [E8-13032]

Download as PDF 33094 Federal Register / Vol. 73, No. 113 / Wednesday, June 11, 2008 / Notices FEDERAL RESERVE SYSTEM Change in Bank Control Notices; Acquisition of Shares of Bank or Bank Holding Companies The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices also will be available for inspection at the office of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than June 26, 2008. A. Federal Reserve Bank of Kansas City (Todd Offenbacker, Assistant Vice President) 1 Memorial Drive, Kansas City, Missouri 64198–0001: 1. Peter Joseph Fiene and Jane Frances Fiene, both of Overland Park, Kansas, and the Patrick Robert Fiene Family Irrevocable Trust No. 1, Peter Joseph Fiene, trustee, to acquire voting shares of BOR Bancorp, and thereby indirectly acquire voting shares of Bank of Rothville, both in Rothville, Missouri. Board of Governors of the Federal Reserve System, June 6, 2006. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E8–13032 Filed 6–10–08; 8:45 am] BILLING CODE 6210–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention sroberts on PROD1PC70 with NOTICES Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Board Meeting Times and Dates (All times are Central Daylight Time): 9 a.m.–5 p.m., June 24, 2008. 9 a.m.–5 p.m., June 25, 2008. 9 a.m.–2 p.m., June 26, 2008. VerDate Aug<31>2005 16:13 Jun 10, 2008 Jkt 214001 Public Comment Times and Dates (All times are Central Daylight Time): 5 p.m.–6 p.m., June 24, 2008. 7:30 p.m.–8:30 p.m., June 25, 2008. Place: Millennium Hotel St. Louis, 200 South 4th Street, St. Louis, MO 63102, Telephone (314) 241–9500, Fax (314) 516– 6149. Status: Open to the public, limited only by the space available. The meeting space accommodates approximately 75 to 100 people. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program (EEOICP) Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and will expire on August 3, 2009. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advise the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters to be Discussed: The agenda for the Advisory Board meeting includes: NIOSH Program Status Update; Special Exposure Cohort (SEC) Petitions for: Y–12 Plant, Dow Chemical Company, and Spencer Chemical Company; SEC Petition Updates: Chapman Valve, Rocky Flats Plant, Blockson Chemical Company, Area IV of the Santa Susana Field Laboratory, Massachusetts Institute of Technology (MIT), Texas City Chemicals; Presentation by the Office of Compensation Analysis and Support (OCAS) on special science journal publication; a presentation on Board interactions with Congressional staffers; Department of Labor (DOL) Update; Department of Energy (DOE) Update including data access and security; Work Group reports; Subcommittee on Dose PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 Reconstruction Reviews Report; and Board Future Plans and Schedules. The agenda is subject to change as priorities dictate. In the event an individual cannot attend, written comments may be submitted according to the policy provided below. Any written comments received will be provided at the meeting and should be submitted to the contact person below well in advance of the meeting. Policy on Redaction of Board Meeting Transcripts (Public Comment), (1) If a person making a comment gives his or her name, no attempt will be made to redact that name. (2) NIOSH will take reasonable steps to ensure that individuals making public comment are aware of the fact that their comments (including their name, if provided) will appear in a transcript of the meeting posted on a public Web site. Such reasonable steps include: (a) A statement read at the start of each public comment period stating that transcripts will be posted and names of speakers will not be redacted; (b) A printed copy of the statement mentioned in (a) above will be displayed on the table where individuals sign up to make public comment; (c) A statement such as outlined in (a) above will also appear with the agenda for a Board Meeting when it is posted on the NIOSH Web site; (d) A statement such as in (a) above will appear in the Federal Register Notice that announces Board and Subcommittee meetings. (3) If an individual in making a statement reveals personal information (e.g., medical information) about themselves that information will not usually be redacted. The NIOSH FOIA coordinator will, however, review such revelations in accordance with the Freedom of Information Act and the Federal Advisory Committee Act and if deemed appropriate, will redact such information. (4) All disclosures of information concerning third parties will be redacted. (5) If it comes to the attention of the DFO that an individual wishes to share information with the Board but objects to doing so in a public forum, the DFO will work with that individual, in accordance with the Federal Advisory Committee Act, to find a way that the Board can hear such comments. Contact Person for More Information: Christine Branche, PhD, Executive Secretary, NIOSH, CDC, 395 E. Street, SW., Suite 9200, Washington, DC 20201, Telephone (513) 533–6800, Toll Free 1 (800) 35–NIOSH, Email ocas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 4, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–13043 Filed 6–10–08; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\11JNN1.SGM 11JNN1

Agencies

[Federal Register Volume 73, Number 113 (Wednesday, June 11, 2008)]
[Notices]
[Page 33094]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-13032]



[[Page 33094]]

=======================================================================
-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Change in Bank Control Notices; Acquisition of Shares of Bank or 
Bank Holding Companies

    The notificants listed below have applied under the Change in Bank 
Control Act (12 U.S.C. 1817(j)) and Sec. [thinsp]225.41 of the Board's 
Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. 
The factors that are considered in acting on the notices are set forth 
in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)).
    The notices are available for immediate inspection at the Federal 
Reserve Bank indicated. The notices also will be available for 
inspection at the office of the Board of Governors. Interested persons 
may express their views in writing to the Reserve Bank indicated for 
that notice or to the offices of the Board of Governors. Comments must 
be received not later than June 26, 2008.
    A. Federal Reserve Bank of Kansas City (Todd Offenbacker, Assistant 
Vice President) 1 Memorial Drive, Kansas City, Missouri 64198-0001:
    1. Peter Joseph Fiene and Jane Frances Fiene, both of Overland 
Park, Kansas, and the Patrick Robert Fiene Family Irrevocable Trust No. 
1, Peter Joseph Fiene, trustee, to acquire voting shares of BOR 
Bancorp, and thereby indirectly acquire voting shares of Bank of 
Rothville, both in Rothville, Missouri.

    Board of Governors of the Federal Reserve System, June 6, 2006.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E8-13032 Filed 6-10-08; 8:45 am]
BILLING CODE 6210-01-S